NEXT Oncology Joins Proxima Clinical Research Early Phase Oncology Network
The addition of NEXT Oncology investigators expands Proxima CRO’s Phase I clinical trials network.
CRO Proxima Clinical Research is expanding its Early Phase Oncology Network (EPON) with the addition of NEXT Oncology, a Phase I clinical trial treatment center. Serving patients out of Virginia, Austin, Dallas, San Antonio, and abroad in Barcelona and Madrid, NEXT Oncology is an early adopter within the Proxima CRO EPON.
Launched in November 2017 and headquartered in the Texas Medical Center Innovation Center in Houston, Proxima CRO has a vast network of cancer research clinics in the United States. Its intent is to advance conceptual development and translational applications, as well serve as a conduit to innovative treatment modalities in investigational cancer therapies.
Reference: NEXT Oncology joins Proxima Clinical Research Early Phase Oncology Network to Advance Investigational Cancer Therapies. HOUSTON, Texas– July 10, 2023.
